17 completed, 3 unknown, 2 not yet recruiting, 2 recruiting. 15 Phase 2, 8 Phase 1, 6 Phase 3, 3 Phase 4.
Follow Bulk Drugs: new trials by email Literature Review of Bulk Drugs trials Research Report on Bulk Drugs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label, Single-arm Trial of Ganaxolone in CDD Patients 6 Months to Less Than 2 Years Old Ganaxolone - CDKL5 Deficiency Disorder | Phase 3 | Not yet recruiting | Immedica Pharma AB | 12 | 2027-03-01 | 2026-11-04 |
| Study of AB-110 in Healthy and Hypertensive Participants Active drug, AB-110 Matching Placebo - Hypertension (HTN), Healthy Adult Participants | Phase 1 | Not yet recruiting | Antlia Bioscience, Inc | 104 | 2026-11-01 | 2026-11-04 |
| Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder Naltrexone group A, Naltrexone, Psychoeducational - Gaming Disorder | Phase 2 | Recruiting | University of Sao Paulo | 40 | 2026-07-01 | 2026-07-27 |
| SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) SC1011, Placebo comparator - Idiopathic Pulmonary Fibrosis | Phase 2 / Phase 3 | Recruiting | Guangzhou JOYO Pharma Co., Ltd | 210 | 2023-06-06 | 2024-11-19 |
| Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease Dapagliflozin 10mg Tab, Placebo - Myocardial Ischemia | Phase 1 | Completed | University of Virginia | 35 | 2023-06-06 | 2026-11-06 |
| A Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid Tumors RGT-419B - Breast Cancer, Advanced Solid Tumor | Phase 1 | Active not recruiting | Regor Pharmaceuticals Inc. | 40 | 2023-04-17 | 2026-08-27 |
| Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients Letermovir - Cytomegalovirus Infections, Infection in Solid Organ Transplant Recipients | Phase 4 | Completed | Tufts Medical Center | 21 | 2023-02-02 | 2026-10-26 |
| Safety and Efficacy of HB-1 for Panic Disorder HB-01, Placebo - Panic Disorder | Phase 2 | Completed | HB BioTech, LLC | 86 | 2022-02-03 | 2025-03-18 |
| Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert Sham Injector, FAI Insert - Uveitis, Uveitis, Posterior | Phase 3 | Terminated | EyePoint Pharmaceuticals, Inc. | 12 | 2021-10-13 | 2024-12-19 |
| Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery Active drug, Placebo, Injection of Ropivacaine - Ultrasound-guided transverse abdominal plane block - Pain, Postoperative, Pain, Abdominal | Phase 4 | Completed | Claus Anders Bertelsen, PhD, MD | 360 | 2021-01-14 | 2025-08-07 |
| Pharmacokinetics of PN-235 in Healthy Volunteers PN-235, Placebo - Healthy Volunteers | Phase 1 | Completed | Protagonist Therapeutics, Inc. | 107 | 2020-11-12 | 2022-02-18 |
| Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management Patiromer Powder for Oral Suspension [Veltassa], Placebo - Hyperkalemia | Phase 4 | Terminated | Comprehensive Research Associates | 115 | 2020-10-08 | 2023-08-31 |
| Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults LB-102 - Schizophrenia | Phase 1 | Completed | LB Pharmaceuticals Inc. | 64 | 2020-01-22 | 2020-12-10 |
| Efficacy and Safety of Angong Niuhuang Wan for Stroke Angong Niuhuang Wan, Angong Niuhuang Wan Placebo - Stroke (CVA) or TIA | Phase 2 / Phase 3 | Unknown | Chinese University of Hong Kong | 100 | 2019-10-15 | 2021-01-29 |
| Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis X0002 Spray, Ibuprofen Tablet, Ibuprofen Placebo Tab - KNEE OSTEOARTHRITIS | Phase 2 | Completed | Tianjin XinChen-Techfields Pharma Co., LTD. | 353 | 2018-07-16 | 2020-01-13 |
| Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction Vitamin D3 50000 UNT Oral Capsule, Placebo oral capsule - Vitamin D Deficiency, Non-ST Elevation Myocardial Infarction (nSTEMI) | Phase 2 | Unknown | Isfahan University of Medical Sciences | 70 | 2018-05-01 | 2018-08-20 |
| Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women Conjugated Equine Estrogen, Placebo - Arthralgia | Phase 2 | Unknown | Hospital de Clinicas de Porto Alegre | 72 | 2017-03-01 | 2019-10-14 |
| A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes TF0023 - Ischemic Stroke | Phase 2 | Suspended | Techfields Inc | 225 | 2017-03-01 | 2024-01-05 |
| Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation Macitentan 10mg, Placebo sugar pill - Pulmonary Hypertension | Phase 2 | Completed | Actelion | 57 | 2016-03-28 | 2025-03-30 |
| Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease Deferiprone, Placebo - Parkinson Disease | Phase 2 | Completed | University Hospital, Lille | 372 | 2016-02-09 | 2026-02-05 |
Showing 20 of 29. Sign in to see all of them.
Osteoarthritis, Knee (2) · Pain, Postoperative (2) · Parkinson Disease (2) · Abdominal Pain (1) · Agnosia (1) · Arthralgia (1) · Blood Coagulation Disorders (1) · Breast Neoplasms (1) · CDKL5 deficiency disorder (1) · Colonic Neoplasms (1) · Coronary Artery Disease, Autosomal Dominant, 1 (1) · Cytomegalovirus Infections (1) · Dyskinesias (1) · Emergencies (1) · Hyperkalemia (1)
EyePoint Pharmaceuticals, Inc. (2) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (2) · Ache Laboratorios Farmaceuticos S.A. (1) · Actelion (1) · Antlia Bioscience, Inc (1) · Chinese University of Hong Kong (1) · Christian Fenger-Eriksen (1) · Claus Anders Bertelsen, PhD, MD (1) · Comprehensive Research Associates (1) · Guangzhou JOYO Pharma Co., Ltd (1) · HB BioTech, LLC (1) · Hospital de Clinicas de Porto Alegre (1) · Immedica Pharma AB (1) · Isfahan University of Medical Sciences (1) · KAI Pharmaceuticals (1)
United States (12) · Brazil (3) · China (3) · Denmark (2) · France (2) · Germany (2) · New Zealand (2) · United Kingdom (2) · Australia (1) · Austria (1) · Belgium (1) · Czechia (1) · Hong Kong (1) · Hungary (1) · India (1)
Chongxi Yu, Ph.D (1) · Chongxi Yu, Ph.D. (1) · Claus A Bertelsen, PhD (1) · David Devos, MD, PhD (1) · David Walling (1) · Glenn Jaffe, MD (1) · Gregory Bell, MD (1) · Hermano Tavares (1) · Jennifer K Chow, MD, MS (1) · Jian Zhang, MD (1) · Lukasz Biernat, MD (1)
PMID 29380903, PMID 32624244, PMID 32726602, PMID 34851250, PMID 36449420, PMID 36517284, PMID 37308268, PMID 39542642, PMID 39635465, PMID 39952690, PMID 39994048, PMID 40629250, PMID 41316871, PMID 41730555
2015 (2), KL2TR003016 (1)